A UK SME has developed novel wound diagnostic kits that detect elevated host protease activity (EPA) and bacterial protease activity (BPA) that enables a more effective treatment regime to be undertaken. The products offer significant potential savings for health services when this diagnostic capability is correctly implemented into their woundcare protocols. The company is looking for partners via a distribution services agreement within identified European markets.
Spanish technology company offers whole software development life-cycle for critical systems under outsourcing agreement
A Spanish company, specialised in services, products and solutions in the field of telecommunications, control …